Implantology in patients affected by systemic diseases and on polypharmacy

被引:0
|
作者
Morelli, Chiara [1 ]
Salerno, Eleonora [1 ]
Pispero, Alberto [2 ]
Franchini, Roberto [2 ]
Lombardi, Niccolo [2 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy
[2] Univ Milan, ASST Santi Paolo & Carlo, Osped San Paolo, SC Odontostomatol 2,Dipartimento Sci Biomed Chiru, Milan, Italy
关键词
Polypharmacy; Systemic diseases; Implantology; Implant success; Implant complications; SEROTONIN REUPTAKE INHIBITORS; DENTAL IMPLANTS; MEDICATIONS; SURGERY; RISK; OSSEOINTEGRATION; PLACEMENT; SURVIVAL; OUTCOMES; IMPACT;
D O I
10.19256/d.cadmos.04.2022.05
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
OBJECTIVES The progressive increase in age in the general population, in the European Union and in particular in Italy, is necessarily leading dentists to interface with patients affected by multiple concomitant systemic diseases. These patients, who often are in polytherapy, increasingly require implant-prosthetic rehabilitation for their total or partial edentulousness. In these patients, prosthetic rehabilitation takes on an important significance, in order to guarantee a better quality of life and a re-appropriation of fundamental actions for social and psychological well-being such as eating, talking and smiling. Therefore, a careful study of the patient's medical history helps to minimize intra- and post-operative complications. The objective of this manuscript is to describe the relationship between systemic diseases, drug therapies and the decision-making process, as well as surgical rehabilitation, which every specialist must evaluate interfacing with a patient affected by systemic diseases and in drug polytherapy. MATERIALS AND METHODS This review emphasizes the importance of the patient's general health and the impact of drug therapies on implant rehabilitation. It is important to consider how some medical conditions can increase the risk of treatment failure or increase the risk of post-operative complications. Recent research of the scientific literature was carried out to guarantee, on the basis of up-to-date clinical data, useful advice to deal with the most common diseases and with their pharmacological therapies. Drug interactions in patients undergoing systemic polytherapy represent a problem which is difficult to manage even by healthcare professionals; therefore, adequate knowledge about drug therapies is a conditio sine qua non for a reliable implant rehabilitation surgery. CONCLUSIONS Polytherapy is crucial for the dentist who intends to deal with a patient with multiple systemic diseases and the continuous research, through the use of recent sources, allows to build a complete picture of the risk factors, the relative and absolute contraindications for this kind of rehabilitation, so as to reduce the risk of intra- and post-operative complications. In addition, the evaluation of the patients' medical condition ensures higher percentage of success and survival implant rate. CLINICAL SIGNIFICANCE It is imperative, in a population that has a high life expectancy and with an increasing incidence of chronic diseases, that the dentist is ready to deal with these patients with extreme accuracy. Scientific evidence is an important source that each dentist should analyze treating patients undergoing polytherapy to ensure the most predictable result. The knowledge on drug therapies and patient systemic diseases reduces the risk of errors and disputes in the community of dental practitioners; for this reason, each specialist should strive to acquire an education based on international scientific literature.
引用
收藏
页码:274 / 287
页数:14
相关论文
共 50 条
  • [31] Excessive polypharmacy and survival in polypathological patients
    Jesús Díez-Manglano
    Mercedes Giménez-López
    Vanesa Garcés-Horna
    María Sevil-Puras
    Elena Castellar-Otín
    Paloma González-García
    Isabel Fiteni-Mera
    Teresa Morlanes-Navarro
    European Journal of Clinical Pharmacology, 2015, 71 : 733 - 739
  • [32] Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence
    Kim, Theresa W.
    Walley, Alexander Y.
    Ventura, Alicia S.
    Patts, Gregory J.
    Heeren, Timothy C.
    Lerner, Gabriel B.
    Mauricio, Nicholas
    Saitz, Richard
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (02): : 150 - 159
  • [33] Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families
    Kuo, Chang-Fu
    Grainge, Matthew J.
    Valdes, Ana M.
    See, Lai-Chu
    Luo, Shue-Fen
    Yu, Kuang-Hui
    Zhang, Weiya
    Doherty, Michael
    JAMA INTERNAL MEDICINE, 2015, 175 (09) : 1518 - 1526
  • [34] Dental implant considerations in patients with systemic diseases: An updated comprehensive review
    Mosaddad, Seyed Ali
    Talebi, Sahar
    Keyhan, Seied Omid
    Fallahi, Hamid Reza
    Darvishi, Mohammad
    Aghili, Seyedeh Sara
    Tavahodi, Narges
    Namanloo, Reza Abdollahi
    Heboyan, Artak
    Fathi, Amirhossein
    JOURNAL OF ORAL REHABILITATION, 2024, 51 (07) : 1250 - 1302
  • [35] Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty
    Thanh Xuan Nguyen
    Nguyen, Tu N.
    Anh Trung Nguyen
    Huong Thi Thu Nguyen
    Thu Thi Hoai Nguyen
    Tam Ngoc Nguyen
    Thang Pham
    Huyen Thi Thanh Vu
    AUSTRALASIAN JOURNAL ON AGEING, 2020, 39 (03) : 230 - 236
  • [36] Excessive polypharmacy and survival in polypathological patients
    Diez-Manglano, Jesus
    Gimenez-Lopez, Mercedes
    Garces-Horna, Vanesa
    Sevil-Puras, Maria
    Castellar-Otin, Elena
    Gonzalez-Garcia, Paloma
    Fiteni-Mera, Isabel
    Morlanes-Navarro, Teresa
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (06) : 733 - 739
  • [37] Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital Patients
    Poudel, Arjun
    Peel, Nancye M.
    Nissen, Lisa M.
    Mitchell, Charles A.
    Gray, Leonard C.
    Hubbard, Ruth E.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (08) : 767.e9 - 767.e13
  • [38] Comorbidity and polypharmacy in patients with breast cancer
    Topaloglu, Ulas Serkan
    Ozaslan, Ersin
    BREAST CANCER, 2020, 27 (03) : 477 - 482
  • [39] Implantology in the endentulous patients-An update after 25 years
    Wolfart, Stefan
    Naujokat, Hendrik
    Wiltfang, Joerg
    Kern, Matthias
    IMPLANTOLOGIE, 2017, 25 (04): : 327 - 344
  • [40] Frailty and polypharmacy in the community-dwelling elderly with multiple chronic diseases
    Chuang, Yuan N.
    Chen, Chia C.
    Wang, Chin J.
    Chang, Yu S.
    Liu, Yi H.
    PSYCHOGERIATRICS, 2023, 23 (02) : 337 - 344